In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Iovance Biotherapeutics Inc (NASDAQ: IOVA) closed at $1.75 down -44.79% from its previous closing price of $3.17. In other words, the price has decreased by -$44.79 from its previous closing price. On the day, 111.99 million shares were traded.
Ratios:
For a deeper understanding of Iovance Biotherapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $17.
Piper Sandler Downgraded its Overweight to Neutral on July 29, 2024, whereas the target price for the stock was revised from $19 to $10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 12 ’24 when Maynard Ryan D sold 50,000 shares for $10.06 per share. The transaction valued at 503,000 led to the insider holds 7,500 shares of the business.
Maynard Ryan D bought 50,000 shares of IOVA for $503,104 on Nov 12 ’24.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.75 while its Price-to-Book (P/B) ratio in mrq is 0.76.
Stock Price History:
Over the past 52 weeks, IOVA has reached a high of $13.60, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is -48.90%, while the 200-Day Moving Average is calculated to be -76.16%.
Shares Statistics:
A total of 333.93M shares are outstanding, with a floating share count of 270.44M. Insiders hold about 19.01% of the company’s shares, while institutions hold 64.51% stake in the company.
